Urea Breath Test Systems Market Size, Share, and Growth Forecast, 2026 – 2033

The global urea breath test systems market size is likely to be valued at US$0.8 billion in 2026 and is expected to reach US$1.4 billion by 2033, growing at a CAGR of 6.8% during the forecast period from 2026 to 2033, driven by rising awareness of gastrointestinal disorders, increasing prevalence of helicobacter pylori (H. pylori) in both developed and developing regions, and a growing preference for non-invasive, accurate, and patient-friendly diagnostic methods over traditional endoscopy or serological tests.

These systems are widely used for detecting active infections, confirming eradication post-treatment, and supporting risk assessment for peptic ulcer disease and gastric cancer. Technological advancements in analyzers, including portable and point-of-care devices, have enhanced speed, accuracy, and accessibility, enabling adoption in hospitals, specialized clinics, and diagnostic laboratories. Regulatory focus on early detection and treatment of H. pylori-related complications has bolstered market momentum. Despite strong demand, regional variations in healthcare infrastructure, clinical awareness, and reimbursement policies influence adoption rates.